Friday, November 21, 2014
Print Current Day:
|
|
SESSION 74 SCHEDULE | |
Friday
SESSION 74:
NEW OR IMPROVED TECHNIQUES OR TECHNOLOGIES; SOME HOT CAROTID AND VERTEBRAL TOPICS
|
|
x | |
6:45 AM - 6:50 AM | Cognitive And MRI Changes After Proximal TEVAR And TAVR Show The Need For Cerebral Protection During These Procedures: What Devices Are Available |
Presenter(s):Ian Loftus, MD | |
View Abstract | |
6:51 AM - 6:56 AM | Use Of The VORTEC Technique: Another Method To Facilitate Hypogastric Revascularization During EVAR |
Presenter(s):Zoran Rancic, MD, PhD | |
View Abstract | |
6:57 AM - 7:02 AM | How To Make CEA Safer And Better In 2014 |
Presenter(s):Sebastian E. Debus, MD, PhD | |
View Abstract | |
7:03 AM - 7:08 AM | Optimal Evaluation And Surgical Approaches To Carotid Body Tumors In 2014 |
Presenter(s):John (Jeb) W. Hallett, MD | |
View Abstract | |
7:09 AM - 7:14 AM | What Is New In The Treatment Of Vertebro-Basilar Disease |
Presenter(s):Klaus D. Mathias, MD | |
View Abstract | |
7:15 AM - 7:20 AM | More Common Finding Of Thrombus Overlying A Carotid Plaque During CEA: What Is Its Significance Or Is It Related To The Earlier Performance Of CEA Currently Being Done In Symptomatic Patients |
Presenter(s):Hisham Rashid, FRCS, FRCS(Gen) / Domenico Valenti, DMChir, PhD, FRCS, FRCS(Ed), FEBVS | |
View Abstract | |
7:21 AM - 7:26 AM | Association Between Carotid Plaque Type And Internal Carotid Artery Occlusion: Therapeutic Implications |
Presenter(s):Christos D. Liapis, MD | |
View Abstract | |
7:27 AM - 7:32 AM | How Can MRI Help To Select The Best And Personalized Treatment For A Given Carotid Patient: Can It Measure Plaque Size And Activity Accurately |
Presenter(s):Rachel E. Clough, MD, PhD | |
View Abstract | |
7:33 AM - 7:38 AM | What Can Duplex Ultrasonography Tell Us About Carotid Plaque Area And Juxtaluminal Black Area (JBA): How Do These Correlate With Stroke Risk And Do These Parameters And Stroke Risk Change With Statin Therapy |
Presenter(s):Andrew N. Nicolaides, MS / Stavros Kakkos, MD, PhD | |
View Abstract | |
7:39 AM - 7:44 AM | How Do Ultrasound And Microbubbles Help With Carotid Plaque Evaluation And Selection Of Asymptomatic Patients For CEA Or CAS |
Presenter(s):Chung S. Lim, MBBS, MRCS, PhD / Alun H. Davies, MA, DM, FRCS, FHEA, FEBVS, FACPh | |
View Abstract | |
7:45 AM - 7:52 AM | Panel Discussion |
END OF SESSION 74 | |
SESSION 75 SCHEDULE | |
Friday
SESSION 75:
MORE ABOUT THORACIC AND ABDOMINAL AORTIC DISEASE AND AORTIC DISSECTIONS; LARGE SHEATH ENDOVASCULAR ACCESS
Moderators:Ronald M. Fairman, MD / Nicholas J.W. Cheshire, MD
|
|
x | |
7:52 AM - 7:57 AM | Alseal HQS Sheath To Minimize Blood Loss With Large Diameter Endovascular Devices |
Presenter(s):Claude Mialhe, MD | |
View Abstract | |
7:58 AM - 8:03 AM | DEBATE: Large Sheath Suture Closure Devices: Why Proglide Is Better: Tips And Tricks |
Presenter(s):Carlos H. Timaran, MD | |
View Abstract | |
8:04 AM - 8:09 AM | DEBATE: Large Sheath Suture Closure Devices: Why Prostar Is Better: Tips And Tricks |
Presenter(s):Ian Loftus, MD | |
View Abstract | |
8:10 AM - 8:15 AM | Which Patients Should Not Be Treated By TEVAR For Aneurysms Or TBADs Because Their 3-Year Mortality Or Reintervention Rates Are So High |
Presenter(s):Matt M. Thompson, MD | |
View Abstract | |
8:16 AM - 8:21 AM | Outcomes Of TEVAR For Complicated Acute TBADs Are Favorable: 1-Year Results From The US VALIANT (Medtronic) IDE Trial |
Presenter(s):Rodney A. White, MD / Joseph E. Bavaria, MD | |
View Abstract | |
8:22 AM - 8:27 AM | Multicenter 1-Year Favorable IDE Trial Results Of Conformable Gore C-TAG Device In TEVAR For Acute Complicated TBADs |
Presenter(s):Richard P. Cambria, MD | |
View Abstract | |
8:28 AM - 8:33 AM | Importance Of Biomechanical Factors For Ascending Aortic Endografts: What Can Be Done To Overcome These Factors |
Presenter(s):Rachel E. Clough, MD, PhD / Peter R. Taylor, MA, MChir, FRCS, ARCM | |
View Abstract | |
8:34 AM - 8:39 AM | Cerebral Embolic Injury Silent And Symptomatic During TEVAR: Incidence And Risk Factors: Significance Of Silent MRI Defects: What Can Be Done To Protect Against These Injuries |
Presenter(s):Richard G.J. Gibbs, FRCS | |
View Abstract | |
8:40 AM - 8:45 AM | Potential For Treating Type A Dissections With A Combined Transcatheter Aortic Valve Replacement And Ascending Aortic Stent-Graft: What Will And Will Not Be Possible |
Presenter(s):Christoph A. Nienaber, MD, PhD | |
View Abstract | |
8:46 AM - 8:53 AM | Panel Discussion |
END OF SESSION 75 | |
SESSION 76 SCHEDULE | |
Friday
SESSION 76:
IN HONOR OF DAVID E. SUMNER, MD: CAROTID ARTERY AND SUPRA-AORTIC BRANCH TOPICS
Moderators:Jean-Baptiste Ricco, MD, PhD / Mark A. Adelman, MD
|
|
x | |
8:53 AM - 8:58 AM | How To Pick The Best Stent For CAS: It Is A Patient-Anatomy And Lesion Specific-Choice |
Presenter(s):Patrick Peeters, MD / Marc Bosiers, MD | |
View Abstract | |
8:59 AM - 9:04 AM | How To Improve CAS Results With Better Approaches For Access, Mesh/Membrane Covered Stents (Roadsaver, C-Guard, Scaffold) And Better Embolic Protection: What Is The Evidence |
Presenter(s):Sumaira Macdonald, MBChB (Comm), FRCP, FRCR, PhD | |
View Abstract | |
9:05 AM - 9:10 AM | Will Robotic Assistance With The Magellan Robotic System Help To Navigate The Arch And Its Branches For CAS Less Traumatically |
Presenter(s):Nicholas J.W. Cheshire, MD / Celia Riga, MD | |
View Abstract | |
9:11 AM - 9:16 AM | DEBATE: For Patients Who Are Undergoing CABG And Who Require Carotid Treatment CAS Is The Way To Go: Many Patients Need CAS |
Presenter(s):Mehdi H. Shishehbor, DO, MPH, PhD | |
View Abstract | |
9:17 AM - 9:22 AM | DEBATE: Very Few Patients Need CAS Or CEA With Any Coronary Bypass Procedures |
Presenter(s):Ross Naylor, MD, FRCS | |
View Abstract | |
9:23 AM - 9:28 AM | Outcomes Of CAS For Radiation Induced Carotid Stenosis Are Equal To Those For Typical Arteriosclerotic Carotid Stenosis – Despite Increased Tortuosity Of Carotid Arteries: What Precautions Need To Be Taken |
Presenter(s):Peter L. Faries, MD, FACS | |
View Abstract | |
9:29 AM - 9:34 AM | Behavior Of Extracranial Carotid Aneurysms: How Should They Best Be Treated: Data From An International Registry |
Presenter(s):Gerrit J. de Borst, MD | |
View Abstract | |
9:35 AM - 9:40 AM | Improved Treatment Of Iatrogenic Catheter Related Brachiocephalic Artery Injuries Using Endovascular Techniques: Tips And Tricks |
Presenter(s):Mark K. Eskandari, MD | |
View Abstract | |
9:41 AM - 9:46 AM | How Can Biochemical Markers CRP And BNP Be Helpful In Vascular Patient Management: Can CRP Levels Predict Progression Of Carotid Stenosis |
Presenter(s):Patrick A. Stone, MD | |
View Abstract | |
9:47 AM - 9:52 AM | Diaphragm Of The Cervical Carotid Arteries: An Underdiagnosed Cause Of Cerebral Infarcts: Diagnosis And Treatment |
Presenter(s):Emmanuel M. Houdart, MD | |
View Abstract | |
9:53 AM - 10:00 AM | Panel Discussion |
10:00 AM - 10:10 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 76 | |
SESSION 77 SCHEDULE | |
Friday
SESSION 77:
CAS Vs. CEA RELATED TOPICS: THE FUTURE FOR CAS IS BRIGHT
Moderators:Ross Naylor, MD, FRCS / Frank J. Veith, MD
|
|
x | |
10:10 AM - 10:15 AM | Despite Various Claims, What Is The Current Truth About The Effects Of CAS And CEA On Cognitive Function: Is There A Difference Between The Procedures |
Presenter(s):Kosmas I. Paraskevas, MD | |
View Abstract | |
10:16 AM - 10:21 AM | Carotid Procedures (CEA Or CAS) For Acute Stroke: When Should They Be Done And How |
Presenter(s):Laura Capoccia, MD, PhD | |
View Abstract | |
10:22 AM - 10:27 AM | Outcome Of A High Risk Plaque Study In 6100 Americans: What Does It Tell Us |
Presenter(s):Henrik Sillesen, MD, DMSc | |
View Abstract | |
10:28 AM - 10:33 AM | The Truth About The High Risk Carotid Patient And Which Patients Should Be Enrolled In Future Carotid Trials |
Presenter(s):Gerrit J. de Borst, MD | |
View Abstract | |
10:34 AM - 10:39 AM | Long-Term Stroke Risk After CEA Has Been Lower Than After CAS: Based On VQI And Medicare US Population-Wide Data |
Presenter(s):Philip P. Goodney, MD, MS | |
View Abstract | |
10:40 AM - 10:45 AM | DEBATE: CMS (Medicare) Should Expand Reimbursement For CAS Indications To Include Average Risk Symptomatic And Asymptomatic Carotid Stenosis Patients |
Presenter(s):William A. Gray, MD | |
View Abstract | |
10:46 AM - 10:51 AM | DEBATE: CMS Should Not Expand Reimbursement For CAS Indications To Include Average Risk Symptomatic And Asymptomatic Carotid Stenosis Patients |
Presenter(s):Wesley S. Moore, MD | |
View Abstract | |
10:52 AM - 10:57 AM | Will Recent Improvements In Medical Therapy Lower Stroke Risk In Asymptomatic Carotid Stenosis Patients So Much That Further Treatment Will Be Unnecessary: Are The ACST And ACSRS Studies Now Obsolete And Will They Have To Be Done Again: Is There A High Risk Asymptomatic Patient Group That Will Benefit From CEA Or CAS |
Presenter(s):Andrew N. Nicolaides, MS / Stavros Kakkos, MD, PhD | |
View Abstract | |
10:58 AM - 11:05 AM | Panel Discussion |
THE FUTURE FOR CAS IS BRIGHT | |
Moderator(s): Thomas G. Brott, MD / Wesley S. Moore, MD | |
11:05 AM - 11:10 AM | Why CAS Will Have A Renaissance And What Studies Are Needed To Justify It: The Mesh Covered Scaffold Stent (Gore) Should Help |
Presenter(s):Peter A. Schneider, MD | |
View Abstract | |
11:11 AM - 11:16 AM | How To Improve CAS And Prevent Post-Procedural Strokes After CAS: Clinical Experience With The Roadsaver Micromesh Carotid Stent: How Does The Micromesh Stent Compare To Other Mesh-Covered Stents Like The MicroNet (C-Guard) Stent From InspireMD And the Scaffold Stent From Gore |
Presenter(s):Max Amor, MD | |
View Abstract | |
11:17 AM - 11:22 AM | A New Development In CAS Which Will Improve Results: Is The Cervical Flow Reversal Device (Michi System) From Silk Road The Safest Way To Perform CAS: When Will We Know How Well It Works |
Presenter(s):Christopher J. Kwolek, MD / Richard P. Cambria, MD | |
View Abstract | |
11:23 AM - 11:28 AM | What Is The Pathological And Functional Significance Of Diffusion Weighted MRI (DW MRI) Defects After CEA And CAS: Are They Irrelevant Or A Bad Thing |
Presenter(s):Emmanuel M. Houdart, MD | |
View Abstract | |
INTENSIVE MEDICAL THERAPY WITH PROPER STATIN USAGE ETC. IS A DISRUPTIVE INFLUENCE | |
11:29 AM - 11:34 AM | Intensive Medical Therapy With Proper Statin Usage Etc. Is A Disruptive Influence |
Presenter(s):Thomas G. Brott, MD | |
View Abstract | |
11:35 AM - 11:40 AM | The CREST Trial Did Not Optimize Medical Treatment And Risk Factor Control Especially In the CEA Treated Patients: What Are The Implications |
Presenter(s):Carlos H. Timaran, MD | |
View Abstract | |
11:41 AM - 11:46 AM | How Will ACST 2, SPACE 2 And CREST 2 Change The CAS vs. CEA Game |
Presenter(s):Francesco Setacci, MD / Carlo Setacci, MD | |
View Abstract | |
11:47 AM - 11:52 AM | What Will The ECST-2 Trial Tell Us About CEA, CAS And Medical Treatment: What Is The Significance Of White Matter And Other MRI Lesions |
Presenter(s):Martin M. Brown, MD | |
View Abstract | |
11:53 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 77 | |
SESSION 78 SCHEDULE | |
x | |
1:00 PM - 1:05 PM | What Were The Pathophysiological Mechanisms Leading To Intraprocedural Strokes In ICSS |
Presenter(s):Gerrit J. de Borst, MD | |
View Abstract | |
1:06 PM - 1:11 PM | How To Optimize Outcomes For CAS And CEA By Appropriate Patient Selection And Having Experts In Both Procedures On The Treating Service |
Presenter(s):Carlos Saadeh, MD, FRCSC, FACS | |
View Abstract | |
1:12 PM - 1:17 PM | Dual Antiplatelet Treatment And Tobacco Use May Increase The Rate Of Progression Of Asymptomatic Carotid Stenosis |
Presenter(s):Mahmoud B. Malas, MD, MHS / Bruce A. Perler, MD, MBA | |
View Abstract | |
1:18 PM - 1:23 PM | US National Trends In Utilization Of CAS For Carotid Bifurcation Disease: Effect Of CMS (Medicare) Decision And CREST Publications: Where Is CAS Going |
Presenter(s):Mohammad H. Eslami, MD, RVT | |
View Abstract | |
1:24 PM - 1:29 PM | DEBATE: Treating Recently Symptomatic Carotid Stenosis Patients Rapidly By CEA Trumps All Interventions In Symptomatic Patients: CAS Should Not Be Used In This Setting |
Presenter(s):Ross Naylor, MD, FRCS | |
View Abstract | |
1:30 PM - 1:35 PM | DEBATE: Not So: Rapid CAS In Recently Symptomatic Carotid Stenosis Patients Can Be Done Safely With Results Equal To CEA |
Presenter(s):Sumaira Macdonald, MBChB (Comm), FRCP, FRCR, PhD | |
View Abstract | |
1:36 PM - 1:41 PM | What Is The Long-Term Fate Of The External Carotid Artery After CEA: Why It Matters |
Presenter(s):Russell H. Samson, MD, RVT, FACS | |
View Abstract | |
1:42 PM - 1:47 PM | Clinical And Imaging Strategies For Predicting Long-Term Stroke Risk In Asymptomatic Patients With Carotid Stenosis |
Presenter(s):Ross Naylor, MD, FRCS | |
View Abstract | |
1:48 PM - 1:54 PM | Tips And Techniques For Managing Intraprocedural Complications With CAS |
Presenter(s):Claudio J. Schonholz, MD | |
View Abstract | |
1:54 PM - 2:00 PM | Panel Discussion |
END OF SESSION 78 | |
SESSION 79 SCHEDULE | |
Friday
SESSION 79:
LATE BREAKING AND CONTROVERSIAL TOPICS
Moderators:Samuel R. Money, MD, MBA / Michael B. Silva, Jr., MD
|
|
x | |
2:00 PM - 2:05 PM | Management Of Secondary Hemorrhage From Vein Grafts In Military Extremity Wounds: In A War Setting PTFE Grafts May Be Better Than Vein Grafts |
Presenter(s):Charles J. Fox, MD, FACS | |
View Abstract | |
2:06 PM - 2:11 PM | Plaque Analysis After Lower Extremity Interventional Treatments And Its Impact On Outcomes |
Presenter(s):Hany Zayed, MD | |
View Abstract | |
2:12 PM - 2:17 PM | The Metabolic Syndrome And How Does It Lead To Bad Outcomes With Vascular Procedures Like EVAR And CEA |
Presenter(s):Alan Dardik, MD, PhD | |
View Abstract | |
2:18 PM - 2:23 PM | How Does The Ruby Coil System (From Penumbra) Facilitate Coil Embolization |
Presenter(s):Frank R. Arko, MD | |
View Abstract | |
2:24 PM - 2:29 PM | Intraluminal PTA Is Better In Diabetics With CLI: Tips To Stay Intraluminal |
Presenter(s):Marco G. Manzi, MD | |
View Abstract | |
2:30 PM - 2:35 PM | Renal Artery Stenting Is Still A Useful Procedure Despite The CORAL And ASTRAL Trials: When Is This So |
Presenter(s):Irwin V. Mohan, MBBS, MD, FRCS, FEBVS, FRACS | |
View Abstract | |
2:36 PM - 2:41 PM | Pearls For The Vascular Surgeon/Specialist Managing Patients With Ehlers-Danlos Syndrome |
Presenter(s):James H. Black III, MD | |
View Abstract | |
2:42 PM - 2:47 PM | How To Treat Super Large AAAs 12-15 cm In Diameter: Is Open Or Endo Better |
Presenter(s):Jacques Busquet, MD | |
View Abstract | |
2:48 PM - 2:53 PM | Impact Of Selection Bias In RCTs Comparing EVAR To Open Repair For Ruptured AAAs: This Is A Major Flaw In The Recent Trials Including IMPROVE |
Presenter(s):Jonathan R. Boyle, MD, FRCS | |
View Abstract | |
2:54 PM - 2:59 PM | A Phantom Aorta: Use Of 3D Printer Technology To Facilitate Fenestrated EVAR |
Presenter(s):Benjamin W. Starnes, MD | |
View Abstract | |
3:00 PM - 3:10 PM | Panel Discussion And Break Visits Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 79 | |
SESSION 80 SCHEDULE | |
Friday
SESSION 80:
MORE LATE BREAKING INFORMATION AND UPDATES
Moderators:Mark A. Farber, MD / Gregg S. Landis, MD
|
|
x | |
3:11 PM - 3:16 PM | Endovascular Limb Salvage After Many Failed Open Bypasses And Open Surgical Limb Salvage After Many Failed Endovascular Procedures: Never Give Up |
Presenter(s):Edward Y. Woo, MD | |
View Abstract | |
3:17 PM - 3:22 PM | Technique For Assessing Lower Extremity (Foot) Perfusion Beyond ABI, PVRs And Toe Pressures |
Presenter(s):Mehdi H. Shishehbor, DO, MPH, PhD | |
View Abstract | |
3:23 PM - 3:28 PM | Hybrid Revascularization In CLI Patients: Still An Important And Useful Option: Tips And Tricks |
Presenter(s):Hany Zayed, MD | |
View Abstract | |
3:29 PM - 3:34 PM | Hybrid Revascularizatons For The “No Option” CLI Patient: What Are They And What Are The Results |
Presenter(s):Hisham Rashid, FRCS, FRCS(Gen) | |
View Abstract | |
3:35 PM - 3:40 PM | Optimal Techniques For Endovascular Management Of AAA Patients With Small Heavily Calcified Distal Aortic Necks And Common Iliac Arteries |
Presenter(s):Ronald M. Fairman, MD | |
View Abstract | |
3:41 PM - 3:46 PM | Ischemic Colitis After EVAR: What Is The Pathogenesis And Why Is The Incidence Decreasing |
Presenter(s):Benjamin W. Starnes, MD | |
View Abstract | |
3:47 PM - 3:52 PM | Real Health Consequences To Interventionalists Of Radiation And Wearing Lead: It Is A Big Deal - Largely Unrecognized And What Can Be Done To Lessen These Consequences |
Presenter(s):Lindsay Machan, MD | |
View Abstract | |
3:53 PM - 3:58 PM | Weightless Lead Protection System For Busy Interventionalists: The Zero Gravity Radiation Protection System From CFI Medical Solutions: Advantages And Limitations |
Presenter(s):Mark A. Farber, MD | |
View Abstract | |
3:59 PM - 4:04 PM | At What Size Should Degenerative Femoral Aneurysms Be Repaired: Their Natural History Is Now Better Known And This Has Led To Changed Criteria For Repair |
Presenter(s):Peter F. Lawrence, MD | |
View Abstract | |
4:05 PM - 4:10 PM | Carotid Duplex Studies Can Be Terribly Misleading And Overestimate The Percent Stenosis: What Is The Mechanism: CEA vs. CAS Should Not Be Performed Without A Confirmatory Test |
Presenter(s):Natalie A. Marks, MD, RPVI, RVT | |
View Abstract | |
4:11 PM - 4:16 PM | Carotid Duplex Studies Can Be Terribly Misleading And Miss Or Underestimate A High-Grade Carotid Stenosis: What Is The Mechanism |
Presenter(s):Glenn M. LaMuraglia, MD | |
View Abstract | |
4:17 PM - 4:24 PM | Panel Discussion |
END OF SESSION 80 | |
SESSION 81 SCHEDULE | |
Friday
SESSION 81:
MORE LATE BREAKING INFORMATION AND UPDATES; ADDITIONAL VITAL NEW DATA ON RUPTURED AAAs
Moderators:James May, MD, MS, FRACS, FACS / John J. Ricotta, MD
|
|
x | |
4:24 PM - 4:29 PM | Is There Evidence In 2014 That Inferior Mesenteric Or Lumbar Artery Embolization Before EVAR Is Beneficial And Safe |
Presenter(s):Florian Dick, MD | |
View Abstract | |
4:30 PM - 4:35 PM | Interobserver Variability In Assigning TASC Or SVS Run-Off Scores: Neither Widely Quoted System Is Worth Much In Real World Usage |
Presenter(s):Steven G. Katz, MD | |
View Abstract | |
4:36 PM - 4:41 PM | AAA Patients With Highly Angulated Necks Can Be Treated Successfully If Certain Adjunctive Procedures Are Used: Tips And Tricks On How To Use Them |
Presenter(s):Boonprasit Kritpracha, MD | |
View Abstract | |
4:42 PM - 4:47 PM | Can Endograft Migration After EVAR Be Treated Successfully With Chimney Grafts |
Presenter(s):Ignacio Escotto, MD | |
4:48 PM - 4:54 PM | Panel Discussion |
VITAL NEW DATA ON RUPTURED AAAS AND THEIR TREATMENT | |
4:54 PM - 4:59 PM | How Often After EVAR For Ruptured AAAs Are Type 2 Endoleaks A Problem: How Can They Be Diagnosed And Treated |
Presenter(s):Clark J. Zeebregts, MD, PhD | |
View Abstract | |
5:00 PM - 5:05 PM | How Do Type 2 Endoleaks Behave Differently After Elective EVAR And EVAR For Ruptured AAAs: Implications For Treatment |
Presenter(s):Manish Mehta, MD, MPH | |
View Abstract | |
5:06 PM - 5:11 PM | High Metabolic Activity By PET/CT Correlates With A High Rupture Risk In Patients With A Family History Of AAA: Such Patients Should Have A Lower Diameter Threshold For Repair Than 5.5 cm |
Presenter(s):Natzi Sakalihasan, MD, PhD | |
View Abstract | |
5:12 PM - 5:17 PM | Institutional Transfer Of Ruptured AAA Patients Before Definitive Repair And Its Effect On Mortality: Tips And Tricks For Doing It Right |
Presenter(s):Matthew W. Mell, MD, MS / Ronald L. Dalman, MD | |
View Abstract | |
5:18 PM - 5:23 PM | Technique Of Aortic Balloon Control For Ruptured AAAs: The Technique Is Not Simple |
Presenter(s):Todd Berland, MD / Neal S. Cayne, MD / Frank J. Veith, MD | |
View Abstract | |
5:24 PM - 5:29 PM | Survival After AAA Rupture X3 In The Same Patient Over Many Years; What Is The Mechanism |
Presenter(s):James May, MD, MS, FRACS, FACS | |
View Abstract | |
5:30 PM - 5:35 PM | Onyx Can Be Used Successfully To Treat Some Ruptured AAAs, Ruptured Thoracic Aneurysms And Type I Endoleaks: Tips And Tricks In Its Use And When It Will Fail |
Presenter(s):Thomas Larzon, MD, PhD | |
View Abstract | |
5:36 PM - 5:45 PM | Panel Discussion End of Program J |
END OF SESSION 81 | |
SESSION 82 SCHEDULE | |
Friday
SESSION 82:
ABDOMINAL AORTA AND ILIAC ARTERY RELATED TOPICS
Moderators:Kenneth Ouriel, MD, MBA / Ramon Berguer, MD, PhD
|
|
x | |
6:45 AM - 6:50 AM | Spontaneous Aortic Thrombus In The Absence Of Aortic Pathology: What Is Its Embolic Potential And How Should It Be Treated |
Presenter(s):Cynthia K. Shortell, MD | |
View Abstract | |
6:51 AM - 6:56 AM | Renal Function Decline After EVAR: Is It Important And What Is The Etiology |
Presenter(s):Franco Grego, MD / Giovanni P. Deriu, MD | |
View Abstract | |
6:57 AM - 7:02 AM | CO2 Angiography For EVAR In Patients Intolerant To Contrast: Tips, Tricks And Precautions For Its Use |
Presenter(s):Luigi Inglese, MD | |
View Abstract | |
7:03 AM - 7:08 AM | DEBATE: Current Stent-Grafts Will Allow Better Outcomes With EVAR Than Those Obtained In The RCTs: EVAR I, DREAM And OVER |
Presenter(s):Marc R.H.M. van Sambeek, MD, PhD | |
View Abstract | |
7:09 AM - 7:14 AM | DEBATE: Not So: Current Outcomes For EVAR Will Be No Different From Those In The RCTs And The Conclusions Of These Trials Are Valid Today |
Presenter(s):Jan D. Blankensteijn, MD | |
View Abstract | |
7:15 AM - 7:20 AM | Long-Term Outcomes Of EVAR And Open Repair In A US Medicare Database: How Do These Compare With The RCT (EVAR 1, DREAM And OVER) Outcomes |
Presenter(s):Marc L. Schermerhorn, MD | |
View Abstract | |
7:21 AM - 7:26 AM | Outcomes And QOL Of EVAR In Octogenarians: The Procedure Is Worthwhile: Based On ENGAGE Registry Results |
Presenter(s):Michel M.P. Reijnen, MD, PhD | |
View Abstract | |
7:27 AM - 7:32 AM | Internal Iliac Aneurysms: Challenges And Techniques For Open And Endovascular Repair: At What Size (Diameter) Is Repair Indicated |
Presenter(s):Manju Kalra, MBBS | |
View Abstract | |
7:33 AM - 7:38 AM | DEBATE: AAAs With Straight Short Necks (8-15 mm) Should Be Treated With Standard Endografts |
Presenter(s):Hence J.M. Verhagen, MD, PhD | |
View Abstract | |
7:39 AM - 7:44 AM | DEBATE: Not So: AAAs With Straight Short Necks (8-15 mm) Should Be Treated With Fenestrated Endografts |
Presenter(s):Gustavo S. Oderich, MD, FACS | |
View Abstract | |
7:45 AM - 7:53 AM | Panel Discussion |
END OF SESSION 82 | |
SESSION 83 SCHEDULE | |
Friday
SESSION 83:
MORE ABDOMINAL AORTA RELATED TOPICS
Moderators:Thomas C. Bower, MD / John B. Chang, MD
|
|
x | |
7:53 AM - 7:58 AM | Finite Element Analysis Is A Tool To Predict AAA Rupture Risk: How Can This Be Determined Easily And How Can It Be Combined With Other Risk Factor Data To Better Predict AAA Rupture Risk: What Is “Equivalent Diameter Rupture Risk” And The Vascops System |
Presenter(s):Dittmar Boeckler, MD / Natzi Sakalihasan, MD, PhD / | |
View Abstract | |
7:59 AM - 8:04 AM | How To Prevent Gutter Endoleaks With Parallel Grafts |
Presenter(s):Willem Wisselink, MD / Kak Khee Yeung, MD, PhD | |
View Abstract | |
8:05 AM - 9:10 AM | When Is AAA Repair Justified In Patients With Chronic Renal Insufficiency Or Connective Tissue Disease: By EVAR; By Open Repair |
Presenter(s):Vicente Riambau, MD, PhD | |
View Abstract | |
8:11 AM - 8:16 AM | Techniques And Strategies For Renal Protection During Open Pararenal And Thoracoabdominal Aneurysm Repair |
Presenter(s):Yamume Tshomba, MD / Germano Melissano, MD / Roberto Chiesa, MD | |
View Abstract | |
8:17 AM - 8:22 AM | Why Are The Rates Of AAA Sac Regression So High And Of Type 2 Endoleak So Low With The Endologix AFX Grafts: Is It Related To An Extended Proximal Seal Or Other Factors |
Presenter(s):Zachary M. Arthurs, MD | |
View Abstract | |
8:23 AM - 8:28 AM | Errors In Endograft Sizing And How They Can Influence Outcomes: How To Prevent Them |
Presenter(s):Juan C. Parodi, MD | |
View Abstract | |
8:29 AM - 8:34 AM | Screening For AAAs Should Be More Selective As AAA Demographics Changes And Incidence Decreases |
Presenter(s):Ian Loftus, MD | |
View Abstract | |
8:35 AM - 8:40 AM | There Is Little Glory In Achieving Access But Many Adverse Consequences Result: How To Do It Safely For EVAR And Other Procedures |
Presenter(s):Scott L. Stevens, MD | |
View Abstract | |
8:41 AM - 8:46 AM | Mural Thrombus Formation In The Endograft After EVAR: How Does It Relate To Complications And The Need For Surveillance: When Can Surveillance Protocols Be Relaxed |
Presenter(s):Hence J.M. Verhagen, MD, PhD | |
View Abstract | |
8:47 AM - 8:52 AM | Is There A Difference In Type 2 Endoleak Incidence Or Behavior Between Different Endografts: What Is The Reason |
Presenter(s):Marc L. Schermerhorn, MD | |
View Abstract | |
8:53 AM - 8:58 AM | Value Of Preloaded Catheters And Wires In Fenestrated Stent-Grafts: How Do They Work And How Helpful Are They |
Presenter(s):Konstantinos P. Donas, MD | |
View Abstract | |
8:59 AM - 9:04 AM | How To Predict, Prevent And Treat Iliac Limb Occlusion In EVAR |
Presenter(s):Ronald M. Fairman, MD | |
View Abstract | |
9:05 AM - 9:13 AM | Panel Discussion |
END OF SESSION 83 | |
SESSION 84 SCHEDULE | |
Friday
SESSION 84:
THORACIC AORTA AND ARCH BRANCH RELATED TOPICS
Moderators:Krassi Ivancev, MD, PhD / Marcelo Ferreira, MD
|
|
x | |
9:13 AM - 9:18 AM | Value And Need For Secondary Interventions After TEVAR: What Factors Predict An Increased Likelihood Of A Secondary Intervention |
Presenter(s):Mark K. Eskandari, MD | |
View Abstract | |
9:19 AM - 9:24 AM | Tips And Tricks To Avoid Complications And Improve TEVAR Results: How Well Do Branched Grafts Work In The Aortic Arch |
Presenter(s):Dittmar Boeckler, MD | |
View Abstract | |
9:25 AM - 9:30 AM | Newer Branched Endografts And Large Proximal Scallops For Aortic Arch Lesions |
Presenter(s):Mo S. Hamady, MD, FRCR, EBIR / Nicholas J.W. Cheshire, MD | |
View Abstract | |
9:31 AM - 9:36 AM | Does Endovascular Or Open Surgical Treatment Of TAAAs Yield A Survival Benefit |
Presenter(s):Florian Dick, MD | |
View Abstract | |
9:37 AM - 9:42 AM | With TBADs Secondary Interventions To Get Improved False Lumen Exclusion Is Important: How To Do It With Stents, Plugs, Coils: When Should They Be Done |
Presenter(s):Joseph V. Lombardi, MD | |
View Abstract | |
9:43 AM - 9:48 AM | Thoracoabdominal Aneurysm Sac Perfusion And Motor Evoked Potentials To Decrease Spinal Cord Ischemia With BEVAR Procedures: Tips And Tricks |
Presenter(s):Piotr M. Kasprzak, MD | |
View Abstract | |
9:49 AM - 9:54 AM | How To Protect A Left Internal Mammary Artery Coronary Bypass In Aortic Arch Interventions |
Presenter(s):Tilo Koelbel, MD, PhD | |
View Abstract | |
9:55 AM - 10:00 AM | How Durable Are Today’s TEVAR Devices: What Is The Need For Secondary Interventions To Fix Device Related Problems |
Presenter(s):Ronald M. Fairman, MD | |
View Abstract | |
10:01 AM - 10:10 AM | Panel Discussion |
10:10 AM - 10:30 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 84 | |
SESSION 85 SCHEDULE | |
Friday
SESSION 85:
MORE THORACIC AORTA AND ARCH BRANCH RELATED TOPICS
Moderators:Alan M. Dietzek, MD, RPVI, FACS / Dennis F. Bandyk, MD
|
|
x | |
10:30 AM - 10:35 AM | Endovascular Treatment Of Aortic And Branch Takayasu’s Disease: When Does It Work And When Does It Not: Based On An Asian Experience |
Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS | |
View Abstract | |
10:36 AM - 10:41 AM | Endovascular Treatment Of Takayasu’s Disease: What Is Its Value: Based On A 10-Year South American Experience |
Presenter(s):Arno von Ristow, MD | |
View Abstract | |
10:42 AM - 10:47 AM | What Cardiac Surgeons Do Not Know About Acute Type A And Type B Aortic Dissections |
Presenter(s):Firas F. Mussa, MD | |
View Abstract | |
10:48 AM - 10:53 AM | Value Of Hepatorenal Bypass To Facilitate Treatment Of TBADs And Complex AAAs |
Presenter(s):Joseph S. Giglia, MD | |
View Abstract | |
10:54 AM - 10:59 AM | Retroperitoneal Access To Target Arteries: A Bailout Procedure When Prograde Branch Catheterization Does Not Work For F/B EVAR |
Presenter(s):Eric L.G. Verhoeven, MD, PhD | |
View Abstract | |
11:00 AM - 11:05 AM | Treatment Of Distal Aortic Growth After TEVAR For TBADs |
Presenter(s):James H. Black III, MD | |
View Abstract | |
11:06 AM - 11:14 AM | Panel Discussion |
11:15 AM - 11:20 AM | What Is The Difference Between A Penetrating Aortic Ulcer And A Saccular Aneurysm: Why It Matters |
Presenter(s):Benjamin M. Jackson, MD | |
View Abstract | |
11:21 AM - 11:26 AM | Tips And Tricks For Open Repair After Failed TEVAR |
Presenter(s):Karl H. Orend, MD | |
View Abstract | |
11:27 AM - 11:32 AM | Open Surgical Adjuncts To Preserve Failing Infrarenal Endografts And Creative Non-Femoral Access Options |
Presenter(s):Martin R. Back, MD | |
View Abstract | |
11:33 AM - 11:38 AM | Chronic Aortic Aneurysms After TBADs: Incidence And Treatment Methods: Long-Term Outcomes Are Poor |
Presenter(s):Richard G.J. Gibbs, FRCS | |
View Abstract | |
11:39 AM - 11:44 AM | How Can Patients With An Aorto-Esophageal Fistula After TEVAR Be Salvaged |
Presenter(s):Jürg Schmidli, MD | |
View Abstract | |
11:45 AM - 11:50 AM | How To Identify Healthy Aorta For A Landing Zone In Endovascular Aneurysm Repairs: It May Not Always Be Possible |
Presenter(s):Matthew J. Eagleton, MD | |
View Abstract | |
11:51 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 85 | |
SESSION 86 SCHEDULE | |
Friday
SESSION 86:
CAROTID RELATED TOPICS AND RECENT ADVANCES IN ACUTE STROKE TREATMENT
Moderators:Ali F. AbuRahma, MD / Anthony J. Comerota, MD, FACS, FACC
|
|
x | |
1:00 PM - 1:05 PM | Should Patients With Chronic Renal Insufficiency Undergo CAS Or CEA |
Presenter(s):Ali F. AbuRahma, MD | |
View Abstract | |
1:06 PM - 1:11 PM | Gender Specific Outcomes For CEA And CAS: Results From The SVS Registry Show That CEA Is Better In Both Men And Women |
Presenter(s):Joseph J. Ricotta II, MD, MS | |
View Abstract | |
1:12 PM - 1:17 PM | CAS Is Still Not As Cost Effective As CEA: But That May Change |
Presenter(s):Kosmas I. Paraskevas, MD | |
View Abstract | |
1:18 PM - 1:23 PM | With Symptomatic Carotid Stenosis Are The Results Of NASCET And ECST Obsolete In View Of Advances In Medical Therapy |
Presenter(s):Alison Halliday, MS, FRCS | |
View Abstract | |
1:24 PM - 1:29 PM | Which Asymptomatic Carotid Stenosis Patients Should Currently Be On Statins And Medical Therapy And Which Should Get This Treatment Plus CEA Or CAS: When Will We Know For Sure And What Should We Do Now |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
View Abstract | |
1:30 PM - 1:35 PM | How Common Are Carotid Stent Fractures After CAS And What Is Their Clinical Significance |
Presenter(s):Richard J. Powell, MD | |
View Abstract | |
1:36 PM - 1:42 PM | Panel Discussion |
RECENT PROGRESS IN ACUTE STROKE TREATMENT | |
Moderator(s): Klaus D. Mathias, MD / Mayank Goyal, MD, FRCPC | |
1:42 PM - 1:47 PM | Recent Improvements In Acute Stroke Management: Impact Of New Clot Aspiration Techniques And Stent-Clot Retrievers |
Presenter(s):Stefan Mueller-Hülsbeck, MD | |
View Abstract | |
1:48 PM - 1:53 PM | New Developments In Acute Stroke Endovascular Treatment: Value Of Stent-Clot Retriever Systems (Solitaire From Covidien) Coupled With Balloon Guide Catheters To Decrease Forward Arterial Flow |
Presenter(s):L. Nelson Hopkins, MD | |
View Abstract | |
1:54 PM - 1:59 PM | New Developments In Acute Stroke Management And Endovascular Devices For Clot Removal And Managing Acute Carotid Occlusions: Success And Adverse Event Rates |
Presenter(s):Klaus D. Mathias, MD | |
View Abstract | |
2:00 PM - 2:11 PM | Panel Discussion |
END OF SESSION 86 | |
SESSION 87 SCHEDULE | |
Friday
SESSION 87:
MORE CAROTID RELATED TOPICS
Moderators:R. Clement Darling III, MD / Cynthia K. Shortell, MD
|
|
x | |
2:11 PM - 2:16 PM | Inefficient Distal Embolic Filters A Cause Of Stroke With CAS: What Can Be Done To Offset This |
Presenter(s):Mark H. Wholey, MD / Michael H. Wholey, MD, MBA | |
View Abstract | |
2:17 PM - 2:22 PM | How To Make CAS In Recently Symptomatic Carotid Stenosis Patients Safe: When Can CAS Compete With CEA In Such Patients |
Presenter(s):Francesco Setacci, MD / Carlo Setacci, MD | |
View Abstract | |
2:23 PM - 2:28 PM | CEA Under Local Anesthesia: Was The GALA Trial Misleading: How Can This Lower Costs In The ACA Era |
Presenter(s):Dipankar Mukherjee, MD | |
View Abstract | |
2:29 PM - 2:34 PM | How To Improve The Results Of Early CEA For Stroke |
Presenter(s):R. Clement Darling III, MD | |
View Abstract | |
2:35 PM - 2:40 PM | How To Perform CAS Safely In Patients With A Non-Circumferential Severely Calcified Carotid Stenosis |
Presenter(s):Gioachino Coppi, MD | |
View Abstract | |
2:41 PM - 2:46 PM | The Game Is Finally Changing With Carotid Disease: When And How to Intervene Beyond Good Medical Therapy |
Presenter(s):Jose Fernandes e Fernandes, MD, PhD, FRCS (Eng), FACS | |
View Abstract | |
2:47 PM - 2:52 PM | Tips And Tricks For Performing CAS With Difficult Arch Anatomy |
Presenter(s):Enrico M. Marone, MD / Germano Melissano, MD / Roberto Chiesa, MD | |
View Abstract | |
2:53 PM - 2:58 PM | CEA In Women: Still Searching For Parity In Access To Treatment: Why Does This Occur And What Is Its Impact |
Presenter(s):Cynthia K. Shortell, MD | |
View Abstract | |
2:59 PM - 3:04 PM | Which Specialty Gets The Best Outcomes With CEA; With CAS |
Presenter(s):Ali F. AbuRahma, MD | |
View Abstract | |
3:05 PM - 3:10 PM | Clinical Volume Correlates With Outcomes For CAS: It Is Undeniable |
Presenter(s):Carlos H. Timaran, MD | |
View Abstract | |
3:11 PM - 3:17 PM | Panel Discussion |
3:17 PM - 3:24 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 87 | |
SESSION 88 SCHEDULE | |
Friday
SESSION 88:
LOWER EXTREMITY AND MISCELLANEOUS TOPICS
Moderators:Vivian Gahtan, MD / Calogero Presti, MD
|
|
x | |
3:24 PM - 3:29 PM | Gracilis Muscle Flap To Heal Groin Wounds With Infected Vascular Grafts: How To Do It And Results |
Presenter(s):John F. Eidt, MD | |
View Abstract | |
3:30 PM - 3:35 PM | Significance And Interpretation Of TLR (Target Lesion Revascularization) And Why TLR And Primary Patency Measures In Clinical Trials Can Be Misleading |
Presenter(s):John R. Laird, MD | |
View Abstract | |
3:36 PM - 3:41 PM | Why The TASC Classification Is No Longer Valid As A Treatment Guide |
Presenter(s):Klaus D. Mathias, MD | |
View Abstract | |
3:42 PM - 3:47 PM | Has The Increase In Lower Extremity Interventions Led To Lower Major Amputation Rates |
Presenter(s):Manju Kalra, MBBS | |
View Abstract | |
3:48 PM - 3:53 PM | Tips And Tricks For OCT Guided Crossing Of Difficult SFA And Popliteal CTOs: A Way To Decrease Radiation Exposure |
Presenter(s):Patrick E. Muck, MD, FACS | |
View Abstract | |
3:54 PM - 3:59 PM | Value And Limitations Of Subintimal PTA Of Aortic And Iliac Occlusive Lesions: Tips And Tricks |
Presenter(s):George H. Meier III, MD | |
View Abstract | |
4:00 PM - 4:05 PM | Optimal Strategies For Dealing With Heavily Calcified SFA Lesions |
Presenter(s):Craig M. Walker, MD | |
View Abstract | |
4:06 PM - 4:11 PM | Endovascular Treatment Of Arterial Complications Of Pancreatitis: Tips And Tricks |
Presenter(s):Maria Antonella Ruffino, MD | |
View Abstract | |
4:12 PM - 4:17 PM | Importance Of Distal Embolization After SFA Interventions And How To Prevent And Treat It |
Presenter(s):Nicholas J. Morrissey, MD | |
View Abstract | |
4:18 PM - 4:23 PM | Hybrid Procedures In The Lower Extremity: Are They Effective And Which Are The Factors That Determine Durability |
Presenter(s):Athanasios D. Giannoukas, MSc, MD, PhD, FEBVS | |
View Abstract | |
4:24 PM - 4:31 PM | Panel Discussion |
END OF SESSION 88 | |
SESSION 89 SCHEDULE | |
Friday
SESSION 89:
MORE LOWER EXTREMITY AND MISCELLANEOUS TOPICS
Moderators:Kenneth Ouriel, MD, MBA / Peter A. Schneider, MD
|
|
x | |
4:31 PM - 4:36 PM | Do Anti-MRSA Agents Prophylactically Prevent Groin Infection After Vascular Procedures: A RCT: What Regimen Should We Use |
Presenter(s):Patrick A. Stone, MD | |
View Abstract | |
4:37 PM - 4:42 PM | Key Technical Tips For Preventing Groin Incision Infections And Decreasing Readmissions And Hospital Costs |
Presenter(s):Peter Henke, MD | |
View Abstract | |
4:43 PM - 4:48 PM | In Hemodialysis Diabetic Patients With CLI And Gangrene: When Is A Primary Amputation The Right Treatment Option And When Should Revascularization Be Attempted |
Presenter(s):Mark G. Davies, MD | |
View Abstract | |
4:49 PM - 4:54 PM | How IVUS Can Be Helpful In Treating Lower Extremity Ischemia And The Lesions Causing It |
Presenter(s):Fabrizio Fanelli, MD, EBIR | |
View Abstract | |
4:55 PM - 5:00 PM | A Special New Technique For Spinal Artery Mapping To Aid In Preservation Of Its Flow And Decrease Cord Ischemia With Thoracic Aortic Procedures |
Presenter(s):Jeffrey Indes, MD | |
View Abstract | |
5:01 PM - 5:06 PM | Tips And Tricks For Performing Optimal And Adequate Debridements Of Diabetic Foot Infections |
Presenter(s):Giustino Marcucci, MD | |
View Abstract | |
5:07 PM - 5:12 PM | How Should Lower Extremity Post PTA Dissections Be Managed And Why Do “Bail Out Stenting” Rates Vary So Much |
Presenter(s):Peter A. Schneider, MD | |
View Abstract | |
5:13 PM - 5:18 PM | Tips And Tricks To Make CFA Stenting Successful: When Is It Indicated |
Presenter(s):George H. Meier III, MD | |
View Abstract | |
5:19 PM - 5:24 PM | Tips And Tricks To Make A Radial Artery Approach Applicable To Most Endovascular Interventions |
Presenter(s):Ali Amin, MD, RVT, FACS, FACC | |
View Abstract | |
5:25 PM - 5:30 PM | Spiral Flow Prosthetic Grafts In Lower Extremity Bypasses: 1-Year Results And Beyond |
Presenter(s):Nick J. Shaper, FRCS | |
View Abstract | |
5:31 PM - 5:36 PM | Results And Cost Effectiveness Of Carbon Dioxide As Contrast Media For Revascularization Of TAXD A And B Femoro-Popliteal Lesions: A Prospective RCT |
Presenter(s):Mariana Krutman, MD | |
View Abstract | |
5:37 PM - 5:43 PM | Duplex Guided Angioplasty And Stenting vs. Conventional Endovascular Technique In Femoro-Popliteal Occlusive Disease: Comparative Results |
Presenter(s):Eduardo F. Rocha, MD | |
View Abstract | |
5:43 PM - 5:53 PM | Panel Discussion End of Program K |
END OF SESSION 89 | |
SESSION 90 SCHEDULE | |
Friday
SESSION 90:
MORE STRATEGIC METHODS TO DEAL WITH SAPHENOUS INCOMPETENCE AND VARICOSE VEINS
Moderators:Lowell S. Kabnick, MD, RPhS, FACS, FACPh
|
|
x | |
6:49 AM - 6:54 AM | RCT Comparing Open Surgery, Radiofrequency, Laser Or Foam Sclerotherapy For Varicose Veins |
Presenter(s):Bo G. Eklof, MD, PhD | |
View Abstract | |
6:55 AM - 7:00 AM | Why Is The SVS-VQI Venous Registry Critical |
Presenter(s):Thomas W. Wakefield, MD | |
View Abstract | |
7:01 AM - 7:06 AM | Thermal Ablation On Anticoagulated Patients: Is It Durable And Effective |
Presenter(s):Glenn Jacobowitz, MD | |
View Abstract | |
7:07 AM - 7:12 AM | When LEED Isn’t Enough: The Distribution Of Thermal Energy In The Vein Wall After Endovenous Thermal Ablation |
Presenter(s):Mark S. Whiteley, MS, FRCS | |
View Abstract | |
7:13 AM - 7:18 AM | Investigating The Effects Of Sclerotherapy And MOCA With Histology And Immunocytochemistry |
Presenter(s):Mark S. Whiteley, MS, FRCS | |
View Abstract | |
7:19 AM - 7:24 AM | Extreme C6 Cases And Endovenous Solutions |
Presenter(s):Ignacio Escotto, MD | |
View Abstract | |
7:25 AM - 7:30 AM | Do The Economic Benefits Of Earlier Surgery Trump The Current Conservative Non-Operative Approach To The Healing Of Venous Ulcers |
Presenter(s):Thomas F. O'Donnell, Jr., MD | |
View Abstract | |
7:31 AM - 7:36 AM | Incidence, Causes, And Treatment Of Recurrent Varicose Veins Following Endovenous Thermal Ablation |
Presenter(s):Edward G. Mackay, MD | |
View Abstract | |
7:37 AM - 7:42 AM | Partial Crossectomy With Branch Preservation And Venoplasty Of Saphenous Bulb |
Presenter(s):Gioachino Coppi, MD | |
7:43 AM - 7:48 AM | Use Of Mechanical Chemical Ablation In Non Saphenous Veins |
Presenter(s):Julianne Stoughton, MD, FACS | |
View Abstract | |
7:49 AM - 7:54 AM | Step By Step Use Of Cyanoacrylate For Saphenous Ablation |
Presenter(s):Jose I. Almeida, MD, RPVI, RVT, FACS | |
View Abstract | |
7:55 AM - 8:00 AM | Neurological Complications Of Sclerotherapy For Varicose Veins |
Presenter(s):Edward G. Mackay, MD | |
View Abstract | |
8:01 AM - 8:06 AM | Radiofrequency Treatment Of Perforating Veins For Recalcitrant Venous Ulcers: How To Do It And Does It Help |
Presenter(s):Peter F. Lawrence, MD | |
View Abstract | |
8:07 AM - 8:12 AM | Superficial Vein Thrombophlebitis: To Treat Or Not To Treat |
Presenter(s):Joseph D. Raffetto, MD | |
View Abstract | |
8:13 AM - 8:18 AM | Saphenous Ablation Of Complex Anatomy: Tips And Tricks |
Presenter(s):Jose I. Almeida, MD, RPVI, RVT, FACS | |
View Abstract | |
8:19 AM - 8:24 AM | The Role Of Truncal Ablation In Venous Ulceration: Is Timing Key |
Presenter(s):Manj S. Gohel, MD, FRCS | |
View Abstract | |
8:25 AM - 8:30 AM | Panel Discussion |
END OF SESSION 90 | |
SESSION 91 SCHEDULE | |
Friday
SESSION 91:
MORE STRATEGIES FOR CORRECTING SEVERE DEEP VENOUS REFLUX AND/OR OBSTRUCTION
|
|
x | |
8:31 AM - 8:36 AM | Surgical Reconstruction Of The Deep Veins |
Presenter(s):Stephen A. Black , MD | |
View Abstract | |
8:37 AM - 8:42 AM | Neo-Valve Reconstruction In The Post-Thrombotic Syndrome |
Presenter(s):Marzia Lugli, MD | |
8:43 AM - 8:48 AM | What Is Worse: Obstruction Or Reflux? |
Presenter(s):Mark H. Meissner, MD | |
View Abstract | |
8:55 AM - 9:00 AM | What Comprises The Chronic Venous Obstruction Of Post -Thrombotic Syndrome? |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
View Abstract | |
9:01 AM - 9:06 AM | Reduction Internal Valvuloplasty (RIVAL) - A New Technique For Deep Vein Valve Reconstruction: Early Results |
Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS | |
View Abstract | |
9:07 AM - 9:12 AM | Panel Discussion |
END OF SESSION 91 | |
SESSION 92 SCHEDULE | |
Friday
SESSION 92:
OTHER MISCELLANEOUS VENOUS CONDITIONS
Moderators:Thomas F. O'Donnell, Jr., MD / Joann Lohr, MD
|
|
x | |
9:13 AM - 9:18 AM | Wound Care, Compression, Surgical Treatment, Ancillary Measures And Primary Prevention |
Presenter(s):Thomas F. O'Donnell, Jr., MD | |
View Abstract | |
9:19 AM - 9:24 AM | Anomalous Features Of Iliac Vein Stenosis That Impact Diagnosis And Treatment |
Presenter(s):Seshadri Raju, MD | |
View Abstract | |
9:25 AM - 9:30 AM | Quality Of Life Assessment After Iliac Vein Stenting For DVT From May-Thurner Syndrome |
Presenter(s):Todd Berland, MD | |
View Abstract | |
9:31 AM - 9:36 AM | Optimal Management Of Isolated Gastrocnemius Or Soleal Vein Thrombosis (ISGVT) |
Presenter(s):Clifford M. Sales, MD, MBA | |
View Abstract | |
9:37 AM - 9:42 AM | Non-Venous Vascular Complications Of Pregnancy |
Presenter(s):Joann Lohr, MD | |
View Abstract | |
9:43 AM - 9:48 AM | Knowns And Unknowns About Popliteal Venous Aneurysms |
Presenter(s):Ido Weinberg, MD, MSc | |
View Abstract | |
9:49 AM - 9:54 AM | What Is Short-Stretch Compression And Why Is That Important For Vascular Surgeons? |
Presenter(s):Joseph A. Caprini, MD | |
View Abstract | |
9:55 AM - 10:00 AM | Lymphedema In Cancer Patients Is Usually Due To Venous Obstructions And Therefore Treatable |
Presenter(s):Gerard J. O'Sullivan, MD | |
View Abstract | |
10:01 AM - 10:06 AM | PAVA – More Understanding Of Peri-Adventitial Venous Abnormalities |
Presenter(s):Mark S. Whiteley, MS, FRCS | |
View Abstract | |
10:07 AM - 10:12 AM | Venous Embryology |
Presenter(s):Jean Francois Uhl, MD, FACPh | |
View Abstract | |
10:13 AM - 10:18 AM | RCT Demonstrating The Efficacy And Benefits Of Sulodexide Treatment In Patients With Venous Ulcers |
Presenter(s):Joseph D. Raffetto, MD | |
View Abstract | |
10:19 AM - 10:24 AM | AVM And VM Are As Different As Apple And Orange |
Presenter(s):Byung-Boong Lee, MD | |
View Abstract | |
10:25 AM - 10:30 AM | Is There A Role For Percutaneous Suture Mediated Closure Systems In Venous Interventions: Tips And Tricks |
Presenter(s):Brian G. DeRubertis, MD | |
View Abstract | |
10:31 AM - 10:36 AM | Update On Caprini DVT Risk Assessment Score |
Presenter(s):Joseph A. Caprini, MD | |
View Abstract | |
10:37 AM - 10:42 AM | How To Properly Design And Interpret Clinical Trials |
Presenter(s):Thomas W. Wakefield, MD | |
View Abstract | |
10:43 AM - 10:48 AM | Panel Discussion |
END OF SESSION 92 | |
SESSION 93 SCHEDULE | |
Friday
SESSION 93:
PELVIC INCOMPETENCE AND ITS CONSEQUENCES
|
|
x | |
10:49 AM - 10:54 AM | Diagnosis And Treatment Paradigm For Patients With Pelvic Venous Congestion Syndrome |
Presenter(s):Melvin Rosenblatt, MD | |
View Abstract | |
10:55 AM - 11:00 AM | Pelvic Congestion Syndrome: Current Principles Of Diagnostic Duplex Imaging |
Presenter(s):Melvin Rosenblatt, MD | |
View Abstract | |
11:01 AM - 11:06 AM | Pelvic Congestion Syndrome: Current Principles Of Diagnostic Cross-Sectional Imaging |
Presenter(s):Barry Stein, MD, FSIR, FACR | |
View Abstract | |
11:07 AM - 11:12 AM | Should You Worry About The Left Renal Vein When Occluding The Left Ovarian Vein? |
Presenter(s):Jose I. Almeida, MD, RPVI, RVT, FACS | |
View Abstract | |
11:13 AM - 11:18 AM | Embolization Has A Major Role In The Treatment Of Varicocele And Pelvic Congestion Syndrome |
Presenter(s):Lindsay Machan, MD | |
View Abstract | |
11:19 AM - 11:24 AM | Pelvic Vein Reflux – Are Hemorrhoids The Next Target? |
Presenter(s):Mark S. Whiteley, MS, FRCS | |
11:25 AM - 11:30 AM | The Safety Of Coil Embolization Of Pelvic Veins And Subsequent Pregnancy |
Presenter(s):Mark S. Whiteley, MS, FRCS | |
View Abstract | |
11:31 AM - 11:36 AM | Ovarian Vein, Hypogastric Vein Incompetence Or Compression Syndrome: Coil, Stent, Both, Neither? |
Presenter(s):Constantino Pena, MD | |
View Abstract | |
11:37 AM - 11:42 AM | Left Renal Vein Stenting Pitfalls |
Presenter(s):Constantino Pena, MD | |
View Abstract | |
11:43 AM - 11:48 AM | How To Treat Vulvar Veins Before Or After Pelvic Embolization |
Presenter(s):Barrie A. Price, Mr, MD, MS, FRCS | |
View Abstract | |
11:49 AM - 11:54 AM | Acute Or Chronic Ovarian Vein Thrombosis: What To Do? |
Presenter(s):Mikel Sadek, MD | |
View Abstract | |
11:55 AM - 12:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 93 | |
SESSION 94 SCHEDULE | |
Friday
SESSION 94:
MORE STRATEGIES FOR THROMBOEMBOLIC EVENTS IN THE VENOUS SYSTEM INCLUDING THE AXILLO-SUBCLAVIAN SYSTEM
Moderators:Thomas W. Wakefield, MD / Gregory L. Moneta, MD
|
|
x | |
1:00 PM - 1:05 PM | Endovascular Management Of Ilio-Femoral DVT With Percutaneous Thrombectomy And Thrombolysis: Indications, Techniques And Results |
Presenter(s):Ali Amin, MD, RVT, FACS, FACC | |
View Abstract | |
1:06 PM - 1:11 PM | Pharmacomechanical Thrombolysis Of Large Volume (Extensive) DVT Using The Rapid Lysis Technique Minimizing The Need For Catheter Directed Lysis |
Presenter(s):Mark J. Garcia, MD | |
View Abstract | |
1:12 PM - 1:17 PM | Methods Of Aging Of Deep Vein Thrombosis |
Presenter(s):Ian J. Franklin, MS, FRCS (Gen Surg) / Alun H. Davies, MA, DM, FRCS, FHEA, FEBVS, FACPh | |
View Abstract | |
1:18 PM - 1:23 PM | Rheolytic Thrombectomy For Deep Vein Thrombosis: Final Report Of A Prospective Multi-Center Registry |
Presenter(s):Ali Amin, MD, RVT, FACS, FACC | |
View Abstract | |
1:24 PM - 1:29 PM | Appropriate Use Of D-Dimer Testing Can Minimize Over-Utilization Of Venous Duplex Ultrasound In A Contemporary High-Volume Hospital |
Presenter(s):Albeir Y. Mousa, MD | |
View Abstract | |
1:30 PM - 1:35 PM | Portal Vein Thrombosis: Techniques For Treating And Recanalizing |
Presenter(s):Mark J. Garcia, MD | |
View Abstract | |
1:36 PM - 1:41 PM | What’s New In Thoracic Outlet Syndrome Treatment And Reporting Standards: When If Ever Should Neurologic TOS Be Treated? |
Presenter(s):Karl A. Illig, MD | |
View Abstract | |
1:42 PM - 1:48 PM | DEBATE: Warfarin Is Still The Treatment Of Choice For VTE: The Noacs Are Not Ready For Prime Time |
Presenter(s):Joseph A. Caprini, MD | |
View Abstract | |
1:49 PM - 1:54 PM | DEBATE: Warfarin Is NOT Still The Treatment Of Choice For VTE: The Noacs Are Ready For Prime Time |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
View Abstract | |
1:55 PM - 2:00 PM | The Value Of Non-Invasive Diagnosis Of Venous Obstruction At The Thoracic Outlet |
Presenter(s):Enrique Criado, MD, FACS | |
View Abstract | |
2:01 PM - 2:06 PM | Incidence Of Upper Extremity DVT After Central Venous Catheterization And What To Do About It |
Presenter(s):Gregory L. Moneta, MD | |
View Abstract | |
2:07 PM - 2:12 PM | Venous Issues In Thoracic Outlet Syndrome: Lysis, Venoplasty, First Rib Resection: Staged Or Same Setting? |
Presenter(s):Enrique Criado, MD, FACS | |
View Abstract | |
2:13 PM - 2:18 PM | Panel Discussion |
END OF SESSION 94 | |
SESSION 95 SCHEDULE | |
Friday
SESSION 95:
ENDOVASCULAR AND OPEN SOLUTIONS FOR INFERIOR VENA CAVA TUMORS AND OCCLUSIONS
Moderators:Peter Gloviczki, MD / William J. Quinones-Baldrich, MD
|
|
x | |
2:19 PM - 2:24 PM | IVC Replacement For Malignancy: How To Do It And What Is The Best Graft |
Presenter(s):Thomas C. Bower, MD | |
View Abstract | |
2:25 PM - 2:30 PM | Endovascular Reconstruction Techniques For Chronic IVC Occlusions |
Presenter(s):Mark J. Garcia, MD | |
View Abstract | |
2:31 PM - 2:36 PM | Role Of Z-Stent In Iliocaval And Caval Stenting |
Presenter(s):Seshadri Raju, MD | |
View Abstract | |
2:37 PM - 2:42 PM | IVC Agenesis: Is This A Real Entity |
Presenter(s):David M. Williams, MD | |
View Abstract | |
2:43 PM - 2:48 PM | Management Of Tumor Thrombus From Renal Cell Carcinoma Extending Into Supra Hepatic IVC And Right Heart |
Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS | |
View Abstract | |
2:49 PM - 2:54 PM | Patient Selection For In-Line Caval Reconstruction |
Presenter(s):William J. Quinones-Baldrich, MD | |
View Abstract | |
2:55 PM - 3:00 PM | Exposure And Techniques For In-Line Caval Reconstruction |
Presenter(s):William J. Quinones-Baldrich, MD | |
View Abstract | |
3:01 PM - 3:06 PM | Conduit Choices For In-Line Caval Reconstruction |
Presenter(s):Peter Gloviczki, MD | |
View Abstract | |
3:07 PM - 3:12 PM | Caval Tumors |
Presenter(s):William A. Marston, MD | |
View Abstract | |
3:13 PM - 3:18 PM | Catheter-Based Interventions For Caval Thrombosis: Which Is The Best |
Presenter(s):Iris Baumgartner, MD | |
View Abstract | |
3:19 PM - 3:24 PM | Panel Discussion |
END OF SESSION 95 | |
SESSION 96 SCHEDULE | |
Friday
SESSION 96:
VENA CAVA FILTRATION STRATEGIES, PITFALLS, AND COMPLICATIONS AND MORE ABOUT ILIAC VEIN STENTING
Moderators:Paul J. Foley III, MD / Ramesh K. Tripathi, MD, FRCS, FRACS
|
|
x | |
VENA CAVA FILTRATION | |
3:25 PM - 3:30 PM | IVC Filters In Acute DVT: Necessary Or Expensive Luxury? |
Presenter(s):Gerard J. O'Sullivan, MD | |
View Abstract | |
3:31 PM - 3:36 PM | Update On The PRESERVE Vena Cava Filter Study |
Presenter(s):David L. Gillespie, MD | |
View Abstract | |
3:37 PM - 3:42 PM | Remove Tilted IVC Filters Immediately: Complications Are Inevitable |
Presenter(s):Werner Lang, MD | |
View Abstract | |
3:43 PM - 3:48 PM | Indications For IVC Filters – Are They Being Observed? |
Presenter(s):John E. Rectenwald, MD, MS | |
View Abstract | |
3:49 PM - 3:54 PM | Successful Techniques For Challenging IVC Filter Retrieval (Permanent And Temporary IVC Filters) |
Presenter(s):Paul J. Foley III, MD | |
View Abstract | |
3:55 PM - 4:00 PM | Why Aren’t Retrievable IVC Filters Retrieved? |
Presenter(s):Ronald L. Dalman, MD | |
View Abstract | |
4:01 PM - 4:06 PM | Major Complications After IVC Filter Placement And How To Avoid Them |
Presenter(s):Clifford M. Sales, MD, MBA | |
View Abstract | |
4:07 PM - 4:12 PM | Update On The Sentry Bioconvertible Non-Retrieval IVC Filter |
Presenter(s):David Rosenthal, MD | |
View Abstract | |
4:13 PM - 4:18 PM | What Evidence Is There That IVC Filters Save Lives? |
Presenter(s):Gregory L. Moneta, MD | |
View Abstract | |
4:19 PM - 4:24 PM | The Prepic Trial – Fact Or Fiction? |
Presenter(s):John E. Rectenwald, MD, MS | |
View Abstract | |
4:25 PM - 4:30 PM | Panel Discussion |
MORE ON STENTS | |
4:31 PM - 4:36 PM | First Experiences With The Veniti And Zilver Vena Stents |
Presenter(s):Stephen A. Black , MD | |
View Abstract | |
4:37 PM - 4:42 PM | Nitinol Versus Wall Stents For Iliac Vein Stenting For Lower Limb Outflow Obstruction: Does It Really Matter? What Is An Ideal Venous Stent? |
Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS | |
View Abstract | |
4:43 PM - 4:48 PM | VIVO Venous Stent IDE Trial Design |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
View Abstract | |
4:49 PM - 4:54 PM | Pregnancy After Stenting For Ilio-Femoral DVT: Outcome And Complications |
Presenter(s):Gabriel Szendro, MD | |
View Abstract | |
4:55 PM - 5:00 PM | What Is The Nature Of In-Stent Stenosis After Venous Stenting? |
Presenter(s):David M. Williams, MD | |
View Abstract | |
5:01 PM - 5:10 PM | Panel Discussion End of Program M |
END OF SESSION 96 |